Insights & News
Discover more about ProPharma and how its dedicated team of industry-leading experts supports clients at every step through the product lifecycle.
Thought Leadership
ProPharma’s team of dedicated experts provides strategic guidance across the entire product lifecycle, helping pharmaceutical, biotechnology, and medical device companies navigate complex challenges with confidence. By leveraging deep industry expertise and data-driven insights, we deliver tailored solutions that support regulatory compliance, clinical development, and patient safety.
Understanding For-Cause Audits: A GMP Case Study
Opening Scene: A Routine Batch Review, Or So It Seemed It started, as many GMP investigations do, with a routine batch review. But this time, the review wasn't happening on the manufacturing floor; it was taking place within the sponsor's quality organization, as part of ongoing oversight of a...
IND Readiness Isn't a Checkbox Exercise, It's a Regulatory Risk Management Strategy
Why Sponsors Should Pressure-Test Their IND Before Submission For many sponsors, the Investigational New Drug (IND) application is viewed as a procedural milestone, the point at which a development program transitions from preclinical research into human studies. But in today’s regulatory...
Cyberattacks in MedTech: Lessons from Stryker, Intuitive, & FDA's Cybersecurity Expectations
Cybersecurity threats are no longer theoretical risks for medical device manufacturers. They are operational, regulatory, and patient safety events unfolding in real time. Recent cybersecurity incidents involving major MedTech companies, including Stryker and Intuitive Surgical, underscore a...
Resources
ProPharma is committed to delivering dynamic research and perspectives crafted by world-class subject matter experts. ProPharma provides valuable insights to its clients to enable thoughtful decision making, as well as informed resource & investment allocation.
%20-%2004May2026.png)
IND Readiness Diagnostic: 12 Questions Sponsors Should Answer Before Submitting
A Practical Framework to Assess IND Readiness Before Filing Identify gaps early. Reduce FDA risk. Strengthen your submission strategy. Preparing for an Investigational New Drug (IND) submission requires more than assembling documentation. It requires alignment across regulatory strategy, clinical...
Reducing Patient Burden While Maintaining High-Frequency Monitoring in a Hemophilia Gene Therapy Trial
Balancing rigorous clinical oversight with patient accessibility is critical in complex gene therapy trials. Intensive early-phase monitoring and complex protocols can place significant burden on patients, impacting recruitment, retention, and overall study success. This case study explores how a...
%20-%20September%202025.png)
Ensure Launch Readiness, Even on the Tightest Timelines
Expediting Promotional Review to Deliver 60+ Materials in Just 4 Weeks When timelines are compressed and stakes are high, promotional review processes can quickly become a bottleneck. This case study shows how our team partnered with a biopharmaceutical company to accelerate review cycles, ensure...
Press Room
ProPharma is at the forefront of the life sciences industry and continues to innovate and elevate its position as a pharmaceutical and MedTech service provider. Stay up to date on ProPharma's latest news and most recent announcements.
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets
Life Sciences Consulting Leader Validates Science-Based Climate Commitments, Reducing Emissions Across Its Global Operations Raleigh, NC, January 27, 2026 – ProPharma, a leading provider of regulatory, clinical, and compliance services for the life sciences industry, announced today that its...
ProPharma Expands Operations with New Office in Hyderabad
Modern workspace supports continued growth and innovation RALEIGH, December 11, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced the official...
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
New hire elevates strategic labeling solutions to support faster approval and smarter commercialization. RALEIGH, July 8, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment...
Awards
With over 20 years of proven success, ProPharma continues to be acknowledged within the life sciences industry for providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. ProPharma proudly shares its recognition and achievements as its team works to improve the health and safety of patients.
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets
Life Sciences Consulting Leader Validates Science-Based Climate Commitments, Reducing Emissions Across Its Global Operations Raleigh, NC, January 27, 2026 – ProPharma, a leading provider of regulatory, clinical, and compliance services for the life sciences industry, announced today that its...
ProPharma Expands Operations with New Office in Hyderabad
Modern workspace supports continued growth and innovation RALEIGH, December 11, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced the official...
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
New hire elevates strategic labeling solutions to support faster approval and smarter commercialization. RALEIGH, July 8, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment...
Events
ProPharma is committed to engaging with both existing and prospective clients at the right time and in the right place. Speak with a member of the team at one of these upcoming events.
Overcoming Challenges. Advancing Patient Care.
Bringing new therapies to market is more complex than ever. ProPharma helps you navigate regulatory challenges with expert guidance, ensuring compliance and accelerating patient access to life-changing treatments.